Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Gα q Inhibitors

Gα q is one of the alpha subunits of the heterotrimeric G proteins, which are vital components of cellular signaling pathways. These proteins act as molecular switches, transitioning between an active (GTP-bound) and an inactive (GDP-bound) state. When activated by receptors at the cell surface, typically G protein-coupled receptors (GPCRs), the Gα q subunit can activate downstream effectors, one of the most notable being phospholipase Cβ (PLCβ). This, in turn, leads to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), second messengers that propagate the signal within the cell. Given the central role of Gα q in transducing extracellular signals to intracellular responses, its precise regulation is crucial for maintaining cellular homeostasis. Dysregulation of Gα q signaling can contribute to various cellular anomalies, underscoring the importance of understanding and modulating its activity.

Gα q inhibitors are a class of chemical compounds meticulously designed to target and modulate the activity of the Gα q protein. These inhibitors can function by several mechanisms, such as preventing the exchange of GDP for GTP (thus keeping Gα q in its inactive state), blocking the interaction between Gα q and its downstream effectors, or stabilizing the inactive form of the protein. The exact binding sites and modes of action can vary among different inhibitors, but the overarching goal is to modulate the signaling pathways mediated by Gα q.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a selective inhibitor of ROCK (Rho-associated coiled-coil kinase), which is downstream of the Gα q signaling pathway. By inhibiting ROCK, Y-27632 can attenuate Gα q-mediated cellular effects.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. Although PI3K is typically associated with Gα_i signaling, its inhibition can impact pathways cross-talking with Gα q-mediated effects.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$152.00
$214.00
$728.00
$2601.00
$10965.00
$21838.00
$41096.00
5
(1)

Suramin is a polysulfonated naphthylurea that inhibits various growth factors. It can interfere with G protein-coupled receptor signaling, including that of Gα q.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

Manumycin A is a farnesyl transferase inhibitor. By inhibiting farnesyl transferase, it can block the post-translational modification of Gα q, potentially impacting its function.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

ML141 is a selective inhibitor of Cdc42, a member of the Rho GTPase family. Cdc42 is involved in pathways that cross-talk with Gα q signaling.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

GW5074 is an inhibitor of Raf-1 kinase, which can be activated downstream of Gα q. By inhibiting Raf-1, GW5074 can attenuate signaling pathways activated by Gα q.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

Gö 6983 is a broad-spectrum PKC inhibitor. PKC is a direct effector of the Gα q signaling pathway, and its inhibition can down-regulate Gα q-mediated effects.

Tyrphostin AG 1478

175178-82-2sc-200613
sc-200613A
5 mg
25 mg
$96.00
$421.00
16
(1)

AG1478 is a specific inhibitor of EGFR tyrosine kinase. EGFR can cross-talk with Gα q signaling, and its inhibition might affect Gα q-dependent pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent PI3K inhibitor. Like LY294002, it can impact pathways that interact with Gα q-mediated signaling.